Nemvaleukin Alfa not checked

Mural Oncology, Inc · ALKS 4230 Subcutaneous · ALKS 4230 Intravenous

FollowEvery change as it happens, and a Monday email
Stage
 
Next date
None yet
 
Trials
1 active
5 in total · 1 in the EU
Targets
 

What this is

How it works
How it works isn't classified yet
Tested for
Advanced Solid Tumor
Main trialPhase 1/2
“The study will be conducted in 2 cohorts. A single-center design for the tumor microenvironment (TME) cohort (Cohort 1), and a multicenter design for the less frequent intravenous (IV) dosing cohort (Cohort 2).”In the company’s words, NCT04592653 on ClinicalTrials.gov
Other names
ALKS 4230 Subcutaneous · ALKS 4230 Intravenous · ALKS 4230

Other drugs for Advanced Solid Tumor

All 2440 drugs for Advanced Solid Tumor

Coming up0

No dates coming up.

Changes0

Last 90 days

No changes yet. We started recording changes on 6 Nov 2026.

Trials5

TrialPhaseCompletesWhat it tests
Phase 1/2Active, not recruiting Jul 2024 Less Frequent IV Dosing & Tumor Microenvironment (TME) Study of Nemvaleukin Alfa (ALKS 4230) Monotherapy and in Combination With Pembrolizumab (ARTISTRY-3)
Phase 2Completed 8 Oct 2021 A Study of ALKS 4230 (Nemvaleukin Alfa) With Pembrolizumab in Head and Neck Cancer
Phase 2Terminated 8 May 2025 Nemvaleukin Alfa Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Cutaneous or Mucosal Melanoma - ARTISTRY-6
Phase 1/2Completed 1 Mar 2023 A Dose Escalation and Cohort Expansion Study of Subcutaneously-Administered Cytokine ALKS 4230 (Nemvaleukin Alfa) as a Single Agent and in Combination With Anti-PD-1 Antibody (Pembrolizumab) in Subjects With Select Advanced or Metastatic Solid Tumors (ARTISTRY-2)
Phase 1/2Completed 27 Mar 2023 A Study of the Effects of ALKS 4230 (Nemvaleukin Alfa) on Subjects With Solid Tumors
A trial in both registries shows both numbers.

About

Sources
ClinicalTrials.gov updated 18 Nov 2026 · EU trials register (CTIS) updated 18 Nov 2026 · openFDA updated 17 Nov 2026

Follow Nemvaleukin Alfa

Following is part of Solo: you see every change to Nemvaleukin Alfa the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in